Total Payments
$1,217
2023 Payments
$137.27
Companies
20
Transactions
46
Medicare Patients
2,882
Medicare Billing
$302,793
Payment Breakdown by Category
Food & Beverage$1,201 (98.7%)
Education$15.97 (1.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,201 | 45 | 98.7% |
| Education | $15.97 | 1 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Stryker Corporation | $427.08 | 9 | $0 (2019) |
| DePuy Synthes Sales Inc. | $153.97 | 2 | $0 (2023) |
| Medtronic USA, Inc. | $121.54 | 1 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $78.11 | 5 | $0 (2018) |
| Entellus Medical, Inc. | $71.75 | 7 | $0 (2018) |
| Acclarent, Inc | $47.54 | 1 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $45.32 | 3 | $0 (2018) |
| GlaxoSmithKline, LLC. | $36.72 | 2 | $0 (2021) |
| Integra LifeSciences Corporation | $29.02 | 2 | $0 (2020) |
| Medical Device Business Services, Inc. | $28.00 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $137.27 | 1 | DePuy Synthes Sales Inc. ($137.27) |
| 2021 | $28.94 | 2 | GENZYME CORPORATION ($15.98) |
| 2020 | $25.03 | 2 | Integra LifeSciences Corporation ($13.12) |
| 2019 | $248.09 | 7 | Stryker Corporation ($188.05) |
| 2018 | $547.33 | 20 | Stryker Corporation ($239.03) |
| 2017 | $230.60 | 14 | Entellus Medical, Inc. ($70.48) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2023 | DePuy Synthes Sales Inc. | MATRIXMANDIBLE (Device), TRUMATCH | Food and Beverage | In-kind items and services | $137.27 | General |
| Category: CMF-Trauma | ||||||
| 08/18/2021 | GENZYME CORPORATION | LIBTAYO (Biological), LIBTAYO | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Oncology | ||||||
| 08/17/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: IMMUNOLOGY | ||||||
| 02/26/2020 | Ethicon US, LLC | Surgicel Powder (Device), SURGICEL Powder Endoscopic Applicator | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: Biosurgical | ||||||
| 02/06/2020 | Integra LifeSciences Corporation | BILAYER WOUND MATRIX (BWM) (Device), INTEGRA WOUND MATRIX (IWM), AMNIOEXCEL | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: RECON-SKIN AND WOUND | ||||||
| 12/18/2019 | Stryker Corporation | ENTELLUS - XPRESS ENT DILATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $24.76 | General |
| Category: ENTELLUS | ||||||
| 11/28/2019 | Integra LifeSciences Corporation | BILAYER WOUND MATRIX (BWM) (Device), INTEGRA WOUND MATRIX (IWM), AMNIOEXCEL | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: RECON-SKIN AND WOUND | ||||||
| 07/23/2019 | HOSPIRA, INC. | GELFOAM (Device) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: HEMOSTAT | ||||||
| 07/17/2019 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 05/04/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Respiratory | ||||||
| 03/27/2019 | Stryker Corporation | ENTELLUS - XPRESS ENT DILATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $146.30 | General |
| Category: ENTELLUS | ||||||
| 02/23/2019 | Stryker Corporation | ENTELLUS - XPRESS ENT DILATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $16.99 | General |
| Category: ENTELLUS | ||||||
| 12/21/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $11.23 | General |
| Category: Respiratory | ||||||
| 12/07/2018 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $14.72 | General |
| Category: Oncology | ||||||
| 10/26/2018 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/25/2018 | Stryker Corporation | ENTELLUS - XPRESS ENT DILATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $27.78 | General |
| Category: ENTELLUS | ||||||
| 10/19/2018 | Mylan Specialty L.P. | Dymista (Drug) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: Respiratory and Allergy | ||||||
| 10/12/2018 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: RESPIRATORY | ||||||
| 07/02/2018 | Stryker Corporation | SPIROX - LATERA (Device) | Food and Beverage | Cash or cash equivalent | $31.19 | General |
| Category: SPIROX | ||||||
| 06/18/2018 | Stryker Corporation | SPIROX - LATERA (Device) | Food and Beverage | Cash or cash equivalent | $27.80 | General |
| Category: SPIROX | ||||||
| 05/17/2018 | Stryker Corporation | ENTELLUS - XPRESS ENT DILATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $98.91 | General |
| Category: ENTELLUS | ||||||
| 05/02/2018 | Medtronic USA, Inc. | FUSION (Device) | Food and Beverage | In-kind items and services | $121.54 | General |
| Category: Image Guided Surgery Products | ||||||
| 04/04/2018 | Stryker Corporation | ENTELLUS - XPRESS ENT DILATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $49.08 | General |
| Category: ENTELLUS | ||||||
| 04/03/2018 | Stryker Corporation | ENTELLUS - XPRESS ENT DILATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $4.27 | General |
| Category: ENTELLUS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 670 | 927 | $204,635 | $78,859 |
| 2022 | 10 | 567 | 770 | $169,036 | $66,548 |
| 2021 | 14 | 777 | 1,071 | $212,812 | $89,611 |
| 2020 | 17 | 868 | 1,166 | $204,565 | $67,774 |
Total Patients
2,882
Total Services
3,934
Medicare Billing
$302,793
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 221 | 355 | $60,350 | $30,483 | 50.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 72 | 116 | $26,680 | $13,763 | 51.6% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2023 | 90 | 135 | $53,730 | $11,107 | 20.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 89 | 89 | $24,030 | $8,222 | 34.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 31 | 31 | $10,695 | $4,611 | 43.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 55 | 67 | $8,040 | $3,993 | 49.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $4,480 | $1,854 | 41.4% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 48 | 64 | $7,705 | $1,703 | 22.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 13 | 17 | $3,400 | $1,384 | 40.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $2,880 | $978.00 | 34.0% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2023 | 21 | 23 | $2,645 | $759.66 | 28.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 195 | 290 | $49,300 | $23,699 | 48.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 74 | 109 | $25,070 | $13,388 | 53.4% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2022 | 69 | 107 | $42,586 | $8,784 | 20.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 59 | 59 | $15,930 | $6,456 | 40.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 26 | 26 | $8,970 | $3,889 | 43.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 41 | 55 | $6,600 | $3,185 | 48.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 17 | 17 | $5,440 | $2,409 | 44.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 21 | 32 | $6,400 | $2,404 | 37.6% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 44 | 54 | $6,325 | $1,594 | 25.2% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2022 | 21 | 21 | $2,415 | $740.31 | 30.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 208 | 329 | $62,428 | $29,714 | 47.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 96 | 170 | $44,380 | $21,230 | 47.8% |
| 31575 | Diagnostic examination of voice box using flexible endoscope | Office | 2021 | 86 | 126 | $38,756 | $11,570 | 29.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 46 | 46 | $17,144 | $6,900 | 40.2% |
About Dr. Peter Rigas, D.O
Dr. Peter Rigas, D.O is a Otolaryngology/Facial Plastic Surgery healthcare provider based in Carmel, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1871715011.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Rigas, D.O has received a total of $1,217 in payments from pharmaceutical and medical device companies, with $137.27 received in 2023. These payments were reported across 46 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,201).
As a Medicare-enrolled provider, Rigas has provided services to 2,882 Medicare beneficiaries, totaling 3,934 services with total Medicare billing of $302,793. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Otolaryngology/Facial Plastic Surgery
- Location Carmel, IN
- Active Since 05/03/2007
- Last Updated 08/11/2022
- Taxonomy Code 207YX0905X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1871715011
Products in Payments
- ENTELLUS - XPRESS ENT DILATION SYSTEM (Device) $369.36
- MATRIXMANDIBLE (Device) $153.97
- FUSION (Device) $121.54
- OPDIVO (Biological) $78.11
- XprESS Multi-Sinus Dilation System (Device) $70.48
- SPIROX - LATERA (Device) $58.99
- ACCLARENT AERA Eustachian Tube Balloon Dilation System (Device) $47.54
- NUCALA (Biological) $36.72
- BILAYER WOUND MATRIX (BWM) (Device) $29.02
- CMF INSTRUMENTS (Device) $28.00
- Xhance (Drug) $27.35
- XOLAIR (Biological) $25.29
- FASENRA (Drug) $24.47
- Dymista (Drug) $22.10
- CIPRODEX (Drug) $20.03
- GRAFIX/GRAFIXPL/STRAVIX (Biological) $18.83
- GELFOAM (Device) $17.49
- LIBTAYO (Biological) $15.98
- MUGARD (Device) $15.97
- Dexilant (Drug) $13.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.